AU Stock MarketDetailed Quotes

FRE Firebrick Pharma Ltd

Watchlist

0.060
0.0000.00%

20min DelayTrading Aug 28 14:01 AET

11.72MMarket Cap-1500P/E (Static)

Firebrick Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

Total revenue

-79.87%830

4.12K

Operating revenue

-79.87%830

--4.12K

Cost of revenue

Gross profit

-79.87%830

4.12K

Operating expense

40.76%6.86M

4.88M

Selling and administrative expenses

-20.42%659.93K

--829.32K

-Selling and marketing expense

13.03%367.78K

--325.37K

-General and administrative expense

-42.03%292.16K

--503.95K

Research and development costs

84.47%4.09M

--2.22M

Depreciation amortization depletion

37.20%9.52K

--6.94K

-Depreciation and amortization

37.20%9.52K

--6.94K

Other operating expenses

15.44%2.1M

--1.82M

Operating profit

-40.86%-6.86M

-4.87M

Net non-operating interest income (expenses)

1,495.25%39.95K

-2.86K

Non-operating interest income

3,018.35%39.95K

--1.28K

Non-operating interest expense

----

--4.14K

Other net income (expenses)

-97.99%21.72K

1.08M

Other non-operating income (expenses)

-97.99%21.72K

--1.08M

Income before tax

-79.18%-6.8M

-3.8M

Income tax

0

0

Earnings from equity interest net of tax

Net income

-79.18%-6.8M

-3.8M

Net income continuous operations

-79.18%-6.8M

---3.8M

Noncontrolling interests

Net income attributable to the company

-79.18%-6.8M

-3.8M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-79.18%-6.8M

-3.8M

Diluted earnings per share

-22.70%-0.04

-0.0326

Basic earnings per share

-22.70%-0.04

-0.0326

Dividend per share

Accounting Standards

US-GAAP

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022
Total revenue	-79.87%830	4.12K
Operating revenue	-79.87%830	--4.12K
Cost of revenue
Gross profit	-79.87%830	4.12K
Operating expense	40.76%6.86M	4.88M
Selling and administrative expenses	-20.42%659.93K	--829.32K
-Selling and marketing expense	13.03%367.78K	--325.37K
-General and administrative expense	-42.03%292.16K	--503.95K
Research and development costs	84.47%4.09M	--2.22M
Depreciation amortization depletion	37.20%9.52K	--6.94K
-Depreciation and amortization	37.20%9.52K	--6.94K
Other operating expenses	15.44%2.1M	--1.82M
Operating profit	-40.86%-6.86M	-4.87M
Net non-operating interest income (expenses)	1,495.25%39.95K	-2.86K
Non-operating interest income	3,018.35%39.95K	--1.28K
Non-operating interest expense	----	--4.14K
Other net income (expenses)	-97.99%21.72K	1.08M
Other non-operating income (expenses)	-97.99%21.72K	--1.08M
Income before tax	-79.18%-6.8M	-3.8M
Income tax	0	0
Earnings from equity interest net of tax
Net income	-79.18%-6.8M	-3.8M
Net income continuous operations	-79.18%-6.8M	---3.8M
Noncontrolling interests
Net income attributable to the company	-79.18%-6.8M	-3.8M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-79.18%-6.8M	-3.8M
Diluted earnings per share	-22.70%-0.04	-0.0326
Basic earnings per share	-22.70%-0.04	-0.0326
Dividend per share
Accounting Standards	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall